Business Wire

Click Therapeutics Launches Software-Enhanced Drug™ Therapies as Part of New Click SE™ Offering

NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, announced the launch of Software-Enhanced Drug™ therapies, part of ...
Medscape

Evaluation of Personal Digital Assistant Software for Drug Interactions

All software under review was downloaded from the manufacturers' Web sites from December 2002 to July 2003. The following software was evaluated: ePocrates Rx (v. 6.0), Tarascon PharmacopoeiaDeluxe ...
RAPS

FDA releases guidance on labeling of drug use-related software outputs

The US Food and Drug Administration (FDA) has released draft guidance with considerations on how to include software outputs of drug use-related software in prescription labeling. In the draft ...
JD Supra

FDA and Prescription Drug Use Related Software – FDA’s Draft PDURS Guidance Answers Years-Old Questions and Introduces New Ones

FDA’s recent draft guidance, Regulatory Considerations for Prescription Drug Use Related Software, proposes a regulatory framework for software disseminated by a drug sponsor that supplements or ...
JD Supra

FDA Issues New Draft Guidance on Regulatory Considerations for Prescription Drug Use-Related Software

New technologies continue to emerge that improve care for patients taking prescription medications. On September 18, 2023, five years after the Food and Drug Administration sought initial public ...
RAPS

Stakeholders concerned with FDA’s definition of labeling in PDURS guidance

Stakeholders want the US Food and Drug Administration (FDA) to narrow its scope of what it considers labeling in a draft guidance for prescription drug-use-related software (PDURS) frameworks, with ...